Quite a few updates on the very well-recognized trials of AIs in adjuvant therapy are revealed in 2011, confirming The present In the past recommendations.Even though results of completely retrospective studies assessing gene expression signatures as prognostic and predictive parameters are promising, thus far none of those signatures continues to